EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions

Engeng Chen, Gaoyang Cao, Zhangfa Song

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189688 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Engeng Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit nennt 151 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has reshaped the treatment landscape of colorectal cancer (CRC), with the clearest and most durable benefit established in mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) disease. However, framing CRC immunotherapy simply as "MSI-H responsive versus microsatellite stable (MSS) resistant" is no longer sufficient. Recent studies indicate that a subset of proficient mismatch repair (pMMR) colon cancers, particularly in the neoadjuvant setting, can mount clinically meaningful responses to immune checkpoint blockade, suggesting that disease stage, local immune organization, and treatment timing critically influence immunotherapy sensitivity. In parallel, emerging evidence has expanded the relevant immune landscape beyond the tumor bed itself, showing that spatially organized stromal and adipose niches can actively divert tumor-reactive lymphocytes and promote immune escape. These advances shift the central challenge in CRC immunotherapy from simply identifying new agents to defining when and in whom immune resistance is reversible, and which biological bottlenecks-such as vascular dysfunction, myeloid suppression, and spatial immune exclusion-must be overcome. In this context, alternative checkpoint inhibitors, bispecific antibodies, cellular therapies, vaccines, nanotechnology-enabled platforms, and microbiome-targeted approaches remain important, but their translational maturity and evidentiary support differ substantially. Biomarker development is likewise evolving from static genomic classification toward dynamic and mechanism-informed stratification incorporating circulating tumor DNA (ctDNA), chromosomal instability, immune architecture, and treatment-induced response trajectories. This review synthesizes recent advances in CRC immunotherapy while emphasizing evidence hierarchy, biomarker-guided patient selection, and the mechanistic basis of combination strategies. We argue that the next phase of CRC immunotherapy will depend less on the indiscriminate addition of novel agents and more on the rational deployment of immunotherapy across molecularly, spatially, and temporally defined disease states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsImmunotherapyImmune Checkpoint InhibitorsHumansMicrosatellite InstabilityDNA Mismatch RepairTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

Colorectal cancerImmunotherapyMicrosatellite stabilityNovel strategiesirAEs

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou 310016, China.
  • Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou 310016, China. Electronic address: songzhangfa@zju.edu.cn.

Zitieren

APA

Chen, E., Cao, G., & Song, Z. (2026). Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189688

Vancouver

Chen E, Cao G, Song Z. Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189688

BibTeX
@article{Chen2026,
  author = {Chen, Engeng and Cao, Gaoyang and Song, Zhangfa},
  title = {Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189688}
}
Kostenlos starten →